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A 19-year-old male underwent allogeneic peripheral blood
hematopoietic stem cell transplantation with human
leukocyte antigen matched from an unrelated donor after
complete remission of his myelodysplastic syndrome/
myeloproliferative neoplasm with acute leukemic change.
The condition regimen was total body irradiation, cyclo-
phosphamide, and Thymoglobulin; and methotrexate, leu-
covorin, and cyclosporine were used for prophylactic graft-
versus-host disease.
On post-transplantation Day 120, the patient com-
plained of papillomatous and verrucous plaques (lesions)
over the orolabial and nasal areas (Fig. 1A) that developed
within the past month. Virologic test result was positive for
immunoglobulin G of herpes simplex virus. Results of skin
biopsy revealed epidermal necrosis, ballooning degenera-
tion of keratinocytes, and virus inclusion body (Fig. 1C).
The clinical and laboratory picture was consistent withFigure 1. (A) On post-transplantation Day 120, the patient compla
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tion. The patient was treated with intravenous acyclovir for
14 days and the lesions gradually improved (Fig. 1B).
CHSV is defined as atypical mucocutaneous wart-like or
ulcerative HSV infection persisting for at least 1 month [1].
It is associated with human immunodeficiency virus infec-
tion or immunosuppression [2]. Allogeneic stem cell trans-
plantation from human leukocyte antigen-matched sibling
donors is the standard treatment for various hematologic
diseases such as leukemia, lymphoma, aplastic anemia, and
myelodysplastic syndrome [3]. Post-transplantation com-
plications include acute or chronic graft-versus-host dis-
ease, acute kidney injury, nephrotic syndrome, bacterial
infection, invasive fungal infection, veno-occlusive disease,
cytomegalovirus infection, herpes zoster, tuberculosis,
pneumocystis jiroveci infection, graft rejection, and dis-
ease relapse [4]. CHSV presenting as papillomatous and
verrucous plaques (lesions) over the orolabial and nasal
areas is a rare complication.ined of papillomatous and verrucous plaques over the orolabial
adually improved after treatment with intravenous acyclovir for
egeneration of keratinocytes, and virus inclusion body (magni-The primary treatment for CHSV is antiviral therapy,
particularly using thymidine kinase-dependent antivirals
such as acyclovir, valacyclovir, and famciclovir [5]. Misdi-
agnosis is common and can delay treatment.y Elsevier Taiwan LLC. All rights reserved.
336 Letter to the EditorComplementary diagnostic methods such as histology,
immunohistology, cell culture, and polymerase chain re-
action are needed to diagnose CHSV accurately. The limi-
tation of this study was that the virologic test result for
immunoglobulin G of herpes simplex virus and skin biopsy
did not indicate the definite diagnosis.
This report shows that CHSV is a rare complication of
allogeneic peripheral blood hematopoietic stem cell
transplantation, for which treatment with intravenous
acyclovir for 14 days provided gradual improvement.
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